Safety and feasibility of carboplatin with vinorelbine in patients with advanced non-small cell cancer: A prospective non-randomized study
Latest Information Update: 04 Mar 2021
At a glance
- Drugs Carboplatin (Primary) ; Vinorelbine (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Adverse reactions
- 04 Mar 2021 New trial record
- 31 Jan 2021 Results presented at the 2020 World Conference on Lung Cancer